MCID: GST078
MIFTS: 40

Gastrointestinal Allergy malady

Categories: Immune diseases, Gastrointestinal diseases

Aliases & Classifications for Gastrointestinal Allergy

Aliases & Descriptions for Gastrointestinal Allergy:

Name: Gastrointestinal Allergy 12 52 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0060502

Summaries for Gastrointestinal Allergy

Disease Ontology : 12 A hypersensitivity reaction type I disease located in the gastrointestinal tract.

MalaCards based summary : Gastrointestinal Allergy is related to eosinophilic granulomatosis with polyangiitis and peptidic growth factors deficiency. An important gene associated with Gastrointestinal Allergy is AOC1 (Amine Oxidase, Copper Containing 1), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Citalopram and Reboxetine have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and breast, and related phenotypes are hematopoietic system and immune system

Related Diseases for Gastrointestinal Allergy

Diseases related to Gastrointestinal Allergy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 128)
id Related Disease Score Top Affiliating Genes
1 eosinophilic granulomatosis with polyangiitis 10.3 CCL11 ITGAE
2 peptidic growth factors deficiency 10.3 CCL11 IL5
3 hidradenitis suppurativa 10.3 CCL11 CCL5
4 hypercementosis 10.3 CCL5 IL5
5 natural killer cell leukemia 10.3 CCL11 IL5
6 restrictive cardiomyopathy 10.2 IL5 RNASE3
7 renal hypertension 10.2 IL5 RNASE3
8 psychotic disorder 10.2 CCL11 IL4
9 disordered steroidogenesis due to cytochrome p450 oxidoreductase 10.2 CCL11 IL5 TSLP
10 conjunctival concretion 10.2 CCL11 IL5 TSLP
11 retinal vascular disease 10.2 CCL11 IL4
12 necrotizing gastritis 10.2 CCL11 IL5 RNASE3
13 rectum squamous cell carcinoma 10.2 CCL11 CCL5 IL5
14 thelaziasis 10.2 CCL11 IL4 IL5
15 lymphoblastic leukemia 10.2 CCL11 IL4 IL5
16 heart septal defect 10.2 CD79A RNASE3
17 infectious anterior uveitis 10.2 CCL5 IL5 RNASE3
18 penis basaloid carcinoma 10.2 CD79A RNASE3
19 coloboma of optic papilla 10.1 CMA1 RNASE3
20 hypersensitivity vasculitis 10.1 IL4 IL5
21 spastic diplegia 10.1 CCL11 CD79A IL5
22 diabetic angiopathy 10.1 CD79A IL4
23 hydrops of gallbladder 10.1 CCL5 IL4 IL5
24 angioedema 10.1 AOC1 CMA1 RNASE3
25 marasmus 10.1 IL4 IL5 RNASE3
26 spastic paraplegia 3a, autosomal dominant 10.1 IL4 IL5 RNASE3
27 acute gonococcal prostatitis 10.1 IL4 IL5 RNASE3
28 paratyphoid fever 10.1 IL4 IL5 RNASE3
29 colloid adenoma 10.1 CD4 CD79A
30 brown shrimp allergy 10.1 CD79A IL5 RNASE3
31 retinal microaneurysm 10.1 CD4 CD79A
32 metal allergy 10.1 CD79A IL5 RNASE3
33 allescheriosis 10.1 IL4 IL5
34 small intestine lymphoma 10.1 CD79A IL5 RNASE3
35 vulvar disease 10.1 CCL5 CD79A RNASE3
36 isthmus cancer 10.1 CCL11 CD79A IL4
37 latent syphilis 10.1 CCL11 CCL5 IL5 RNASE3
38 46 xy gonadal dysgenesis 10.1 CD4 CD79A
39 tibial adamantinoma 10.1 CD4 CD79A
40 childhood malignant mesenchymoma 10.1 CCL11 CCL5 IL5 RNASE3
41 barbiturate abuse 10.1 CCL11 CD79A IL4
42 coenurosis 10.1 CD79A IL4 IL5
43 loiasis 10.1 CD79A IL4 IL5
44 generalized atherosclerosis 10.0 CD4 CD79A
45 cutaneous fibrous histiocytoma 10.0 CCL11 CCL5 IL4 IL5
46 inflammatory bowel disease 2 10.0 CD79A IL4 IL5
47 bursitis 10.0 CD4 CD79A
48 osteodysplasty precocious of danks mayne and kozlowski 10.0 CCL5 CD79A IL4
49 syphilis 10.0 CD4 CD79A
50 vestibule of mouth cancer 10.0 CD4 IL4

Graphical network of the top 20 diseases related to Gastrointestinal Allergy:



Diseases related to Gastrointestinal Allergy

Symptoms & Phenotypes for Gastrointestinal Allergy

MGI Mouse Phenotypes related to Gastrointestinal Allergy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 AOC1 CCL11 CCL5 CD4 CD79A CMA1
2 immune system MP:0005387 9.32 CD79A CMA1 CRLF2 IL4 IL5 ITGAE

Drugs & Therapeutics for Gastrointestinal Allergy

Drugs for Gastrointestinal Allergy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 924)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
2
Reboxetine Approved, Investigational Phase 4 98769-81-4, 71620-89-8 123628 65856
3
Cyproheptadine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 129-03-3 2913
4
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 75614-87-8, 51-45-6 774
5
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3 26787-78-0 33613 2171
6
Ciprofloxacin Approved, Investigational Phase 4,Phase 2 85721-33-1 2764
7
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1 443-48-1 4173
8
Pancrelipase Approved Phase 4,Phase 2,Phase 1,Early Phase 1 53608-75-6
9
Budesonide Approved Phase 4,Phase 2,Phase 3 51333-22-3 63006 5281004
10
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
11
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 73590-58-6 4594
12
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
14
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
15
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 185243-69-0
16
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
17
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
18
Haloperidol Approved Phase 4,Phase 1,Phase 2 52-86-8 3559
19
Lansoprazole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 103577-45-3 3883
20
Midazolam Approved, Illicit Phase 4,Phase 2,Phase 1 59467-70-8 4192
21
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
22
Magnesium oxide Approved Phase 4,Phase 3,Phase 2 1309-48-4 14792
23
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
24
Glycerol Approved, Experimental Phase 4,Phase 2,Phase 1 56-81-5 753
25
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
26
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1 657-24-9 14219 4091
27
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
28
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1994-09-7, 94-09-7 2337
29
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2 100643-71-8 124087
30
Clarithromycin Approved Phase 4,Phase 2,Phase 3 81103-11-9 84029
31
Erythromycin Approved, Vet_approved Phase 4,Phase 3,Phase 2 114-07-8 12560
32
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
33
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-78-2 2244
34
Vancomycin Approved Phase 4,Phase 2 1404-90-6 441141 14969
35
Liraglutide Approved Phase 4,Phase 2 204656-20-2
36
Insulin Glargine Approved Phase 4 160337-95-1
37
Rabeprazole Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 117976-89-3 5029
38
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1 103-90-2 1983
39
Ketamine Approved, Vet_approved Phase 4,Phase 1,Phase 2 6740-88-1 3821
40
Calcium carbonate Approved Phase 4,Phase 3,Phase 1,Phase 2 471-34-1
41
Indomethacin Approved, Investigational Phase 4,Early Phase 1 53-86-1 3715
42
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1 158966-92-8 5281040
43
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
44
Sunitinib Approved, Investigational Phase 4,Phase 2 341031-54-7, 557795-19-4 5329102
45
Orlistat Approved, Investigational Phase 4 96829-58-2 3034010
46
Clotrimazole Approved, Vet_approved Phase 4,Phase 1,Phase 2 23593-75-1 2812
47
Nystatin Approved, Vet_approved Phase 4,Phase 1,Phase 2 1400-61-9 11953884
48
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
49
Mannitol Approved, Investigational Phase 4,Phase 1,Early Phase 1 69-65-8 453 6251
50
Celecoxib Approved, Investigational Phase 4,Phase 2,Phase 1 169590-42-5 2662

Interventional clinical trials:

(show top 50) (show all 1372)
id Name Status NCT ID Phase
1 Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder Unknown status NCT00209807 Phase 4
2 Manipulation of Visceral Sensitivity and Immune System in IBS Unknown status NCT00418340 Phase 4
3 Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects Unknown status NCT00258141 Phase 4
4 Preoperative Assessment of Colon Tumor Unknown status NCT00114829 Phase 4
5 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4
6 Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study Unknown status NCT01800734 Phase 4
7 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis Unknown status NCT01846962 Phase 4
8 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
9 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
10 Long Term Tapering or Standard Steroids for Nephrotic Syndrome Unknown status NCT00308321 Phase 4
11 Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker Unknown status NCT01072058 Phase 4
12 A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis Unknown status NCT01838174 Phase 4
13 Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia Unknown status NCT00838032 Phase 4
14 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4
15 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4
16 Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis Unknown status NCT02371941 Phase 4
17 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers Completed NCT02674256 Phase 4
18 Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens Completed NCT00557284 Phase 4
19 Pharmacogenetics of Gastrointestinal Bleeding Completed NCT00190255 Phase 4
20 Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome Completed NCT01139736 Phase 4
21 Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding Completed NCT00838864 Phase 4
22 Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients Completed NCT01402089 Phase 4
23 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4
24 Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat Completed NCT00991926 Phase 4
25 The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis Completed NCT01507766 Phase 4
26 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4
27 iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions Completed NCT02552537 Phase 4
28 Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity Completed NCT00636142 Phase 4
29 Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen Completed NCT00346216 Phase 4
30 Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men. Completed NCT02595684 Phase 4
31 Examining the Effects of Antipsychotic Medications on Insulin Sensitivity Completed NCT00895921 Phase 4
32 Centocor Microarray Study of Patients Completed NCT00462072 Phase 4
33 Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes Completed NCT00338949 Phase 4
34 Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo Completed NCT02062710 Phase 4
35 Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder Completed NCT00190749 Phase 4
36 Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists Completed NCT01144832 Phase 4
37 Magnetic Resonance (MR) Colonography With Fecal Tagging Completed NCT00114842 Phase 4
38 Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms Completed NCT00938704 Phase 4
39 Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis Completed NCT01119287 Phase 4
40 Diagnostic Accuracy of Capsule Endoscopy in Small Bowel Crohn's Disease Completed NCT00588653 Phase 4
41 To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses Completed NCT00648973 Phase 4
42 Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation Completed NCT01070680 Phase 4
43 Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD) Completed NCT02805907 Phase 4
44 Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics Completed NCT01411930 Phase 4
45 Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole Completed NCT00205660 Phase 4
46 Tdap Vaccine in Post-Partum Women Completed NCT01711645 Phase 4
47 MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil Completed NCT00332943 Phase 4
48 Anti-TNF Agents for the Treatment of Rheumatoid Arthritis Completed NCT00837434 Phase 4
49 Appendicectomy Skin Closure Technique: Changing Paradigms (ASC) Completed NCT02625987 Phase 4
50 Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea Completed NCT01195090 Phase 4

Search NIH Clinical Center for Gastrointestinal Allergy

Genetic Tests for Gastrointestinal Allergy

Anatomical Context for Gastrointestinal Allergy

MalaCards organs/tissues related to Gastrointestinal Allergy:

39
Testes, Skin, Breast

Publications for Gastrointestinal Allergy

Articles related to Gastrointestinal Allergy:

(show all 22)
id Title Authors Year
1
Dietary elimination of children with food protein induced gastrointestinal allergy - micronutrient adequacy with and without a hypoallergenic formula? ( 25328667 )
2014
2
Effect of raw milk on allergic responses in a murine model of gastrointestinal allergy. ( 24870507 )
2014
3
Guidance for the nutrition management of gastrointestinal allergy in pediatrics. ( 24565537 )
2013
4
Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. ( 20600023 )
2010
5
Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens. ( 16890767 )
2006
6
Gastrointestinal allergy in adults. ( 16292080 )
2005
7
Revisiting the "hygiene hypothesis" in gastrointestinal allergy. ( 17033352 )
2002
8
Gastrointestinal allergy: clinical symptoms and immunological mechanisms. ( 11380898 )
2001
9
A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. ( 10841566 )
2000
10
The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. ( 10350171 )
1999
11
Anti-schistosomal IgE and its relation to gastrointestinal allergy in breast-fed infants of Schistosoma mansoni infected mothers. ( 9707682 )
1998
12
Gastrointestinal allergy to food: a review. ( 9661317 )
1997
13
Analysis and characteristics of mast cell tryptase and eosinophilic cationic protein from human gut mucosa in gastrointestinal allergy. ( 8813193 )
1996
14
Gastrointestinal allergy. ( 7975041 )
1994
15
Food allergens as causative factors of respiratory, skin and gastrointestinal allergy confirmed by skin prick test and specific IgE and IgG4 FAST in children. ( 1292838 )
1992
16
Malrotation in children with symptoms of gastrointestinal allergy and psychosomatic abdominal pain. ( 3993380 )
1985
17
Cromolyn in combined gastrointestinal allergy. ( 6771419 )
1980
18
Childhood gastrointestinal allergy: forbidden fruits. ( 6902927 )
1980
19
Gastrointestinal allergy to soyabean protein in preruminant calves. Antibody production and digestive disturbances in calves fed heated soyabean flour. ( 575570 )
1979
20
Use of cromolyn in combined gastrointestinal allergy. ( 112265 )
1979
21
Gastrointestinal allergy to soyabean protein in preruminant calves. Allergenic constituents of soyabean products. ( 575571 )
1979
22
Protein-losing enteropathy associated with gastrointestinal allergy. ( 4168025 )
1967

Variations for Gastrointestinal Allergy

Expression for Gastrointestinal Allergy

Search GEO for disease gene expression data for Gastrointestinal Allergy.

Pathways for Gastrointestinal Allergy

Pathways related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

(show all 21)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.82 AOC1 CCL11 CCL5 CD4 CD79A IGHE
2
Show member pathways
13.45 CCL11 CCL5 CD4 CRLF2 IL4 IL5
3
Show member pathways
13.21 CCL11 CCL5 CD4 IL4 IL5 ITGAE
4
Show member pathways
13.15 CCL11 CCL5 CD4 IGHE IL4 IL5
5
Show member pathways
12.62 CCL11 CD4 IL4 IL5 RNASE3
6
Show member pathways
12.44 CD4 CD79A IGHE IL4
7
Show member pathways
12.36 CD79A IGHE IL4 IL5
8
Show member pathways
11.97 CRLF2 IL4 IL5 TSLP
9 11.78 CCL11 IGHE IL4
10 11.69 CD4 CD79A IL4 IL5
11 11.67 CD4 IL4 IL5
12 11.52 IL4 IL5 ITGAE
13 11.36 CCL11 IGHE IL4 IL5
14 11.35 CCL11 CCL5 CMA1 IL4 IL5
15 11.09 IL4 IL5 TSLP
16 11.03 CCL11 CD4 CRLF2 IL4 IL5
17 11.02 CD4 IL4 IL5
18 11.01 IL4 IL5
19 11 CD4 CRLF2 IL4 IL5 ITGAE TSLP
20 10.99 CCL11 CCL5 IL4 IL5
21 10.71 IL4 IL5

GO Terms for Gastrointestinal Allergy

Cellular components related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.7 AOC1 CCL11 CCL5 IL4 IL5 RNASE3
2 external side of plasma membrane GO:0009897 9.35 CD4 CD79A IGHE IL4 ITGAE
3 extracellular region GO:0005576 9.32 AOC1 CCL11 CCL5 CMA1 CRLF2 IGHE

Biological processes related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.65 CCL11 CCL5 CD4
2 chemotaxis GO:0006935 9.61 CCL11 CCL5 IL4
3 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.5 CD4 IL4 IL5
4 B cell activation GO:0042113 9.46 CD79A IL4
5 innate immune response in mucosa GO:0002227 9.4 IL4 RNASE3
6 positive regulation of JAK-STAT cascade GO:0046427 9.37 CCL5 IL5
7 regulation of T cell activation GO:0050863 9.26 CCL5 CD4
8 eosinophil chemotaxis GO:0048245 9.16 CCL11 CCL5
9 positive regulation of T cell proliferation GO:0042102 9.13 CCL5 CD4 IL4
10 immune response GO:0006955 9.1 CCL11 CCL5 CD4 IGHE IL4 IL5

Molecular functions related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 CCL11 CCL5 IL4 IL5 TSLP

Sources for Gastrointestinal Allergy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....